General Range

FORZOLID IV

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

FORZOLID IV Infusion by Fortune Labs contains Linezolid 600 mg/300 ml, a prescription oxazolidinone antibiotic used for treating selected serious bacterial infections caused by susceptible Gram-positive microorganisms. Linezolid works by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit. FORZOLID IV may be prescribed for hospital-acquired pneumonia, selected community-acquired pneumonia, complicated skin and soft tissue infections, and certain MRSA or vancomycin-resistant Enterococcus infections when clinically appropriate. Available in a ready-to-use 300 ml sterile intravenous infusion bottle with protective carton packaging, the medicine is intended for administration by trained healthcare professionals. Treatment requires consideration of bacterial susceptibility, blood cell counts, medication interactions, neurological adverse effects and recommended treatment duration.

CategoryGeneral Range

Min. Order100 boxes

Supplied byFortune Labs

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Linezolid Infusion 600 mg/300 ml
Packaging Type: Ready-to-Use Plastic IV Infusion Bottle with Protective Cap and Printed Carton B
Packaging Size: 300ml
Dosage Form: Sterile Intravenous Infusion Solution
Treatment: May treat certain hospital-acquired bacterial lung infections.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana

View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?